<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05615402</url>
  </required_header>
  <id_info>
    <org_study_id>NorwegianSSS BoneWheel</org_study_id>
    <nct_id>NCT05615402</nct_id>
  </id_info>
  <brief_title>Intervention on Bone Health in Wheelchair Users</brief_title>
  <acronym>BoneWheel</acronym>
  <official_title>Improving Bone Health in Wheelchair Users by a Long-term Intervention Combining Bone-specific Exercise and Nutrition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian School of Sport Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sunnaas Rehabilitation Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>HAN University of Applied Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian School of Sport Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The low mechanical loading of bones among wheelchair users leads to an increased risk of bone&#xD;
      fractures and associated complications due to low bone mineral density (BMD). Adding&#xD;
      mechanical loading through physical activity in combination with optimizing nutrition may&#xD;
      counteract these negative consequences in wheelchair users and thereby provide positive&#xD;
      impact for bone health, as well as for physical and mental health.&#xD;
&#xD;
      In this project, a multidisciplinary team will tailor a bone-specific exercise and nutrition&#xD;
      program to increase BMD in sport active and non-active wheelchair users with initial low BMD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary aim of this project is to investigate the effects of combined exercise training&#xD;
      with high mechanical loading of bones and nutritional counselling for improving bone health&#xD;
      in wheelchair users with an initially low-normal to low BMD (Z-score ≤ 0.0). Specifically,&#xD;
      the following objectives are to determine the effects of the intervention on:&#xD;
&#xD;
        1. Bone health, measured as changes in BMD and blood bone markers.&#xD;
&#xD;
        2. Physical health, including body composition and muscular fitness.&#xD;
&#xD;
        3. Mental health, with focus on well-being, QOL and user experience.&#xD;
&#xD;
      The secondary aim is to use this knowledge to develop recommendations and implementation&#xD;
      plans for exercise and nutrition to promote bone health of wheelchair users.&#xD;
&#xD;
      Using a randomized controlled design, participants will undergo an exercise intervention in&#xD;
      which the participants also will receive nutritional optimization for bone remodelling. Main&#xD;
      outcomes are change in BMD, blood bone markers, physical health and mental health parameters.&#xD;
      Based on the outcomes of the RCT, the researchers will develop evidence-based practical&#xD;
      health promoting recommendations and an implementation plan for health practitioners working&#xD;
      with wheelchair users in the municipalities.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2022</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled trial over 24-weeks.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bone mineral density of the spine</measure>
    <time_frame>24-weeks</time_frame>
    <description>Z-score for L1-4</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Bone Loss</condition>
  <condition>Spinal Cord Injuries</condition>
  <condition>Cerebral Palsy</condition>
  <condition>Spina Bifida</condition>
  <condition>Dysmelia</condition>
  <condition>Amputation</condition>
  <arm_group>
    <arm_group_label>Training group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group A: strength training 3x/week + nutrition optimalisation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nutrition group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group B: nutrition optimalisation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bone-specific strength training</intervention_name>
    <description>Muscular strength and rate of force development (RFD) will be assessed in the key exercises of the intervention protocol</description>
    <arm_group_label>Training group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nutrition optimalisation</intervention_name>
    <description>Dietary supplement of protein, vitamin D and Calcium 3x/w Dietary counselling based on individual dietary records</description>
    <arm_group_label>Nutrition group</arm_group_label>
    <arm_group_label>Training group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMD Z-score of the spine ≤ 0 SD&#xD;
&#xD;
          -  primary aid for mobility being a manual wheelchair, i.e. ≥50% of the time&#xD;
&#xD;
          -  18-50 Y&#xD;
&#xD;
          -  congenital (i.e., CP, spina bifida, dysmelia, hip dysplasia) and acquired disabilities&#xD;
             (i.e., SCI, amputation)&#xD;
&#xD;
          -  paraplegic wheelchair users with SCI level at Th6 or lower (or higher partial SCI)&#xD;
&#xD;
          -  ability to perform key exercises (e.g., overhead press)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  tetraplegic wheelchair users&#xD;
&#xD;
          -  injury acquired &lt;2 Y ago&#xD;
&#xD;
          -  change in health and/or medication within the last 3 months&#xD;
&#xD;
          -  fracture within the last 6 months&#xD;
&#xD;
          -  pregnancy or planned pregnancy during the study period&#xD;
&#xD;
          -  language or cognitive barriers affecting the ability to understand all aspects of the&#xD;
             study&#xD;
&#xD;
          -  patients with progressive neurological disease, serious or uncontrollable epilepsy,&#xD;
             endocrine diseases (including diabetes mellitus type 1 or 2, thyroid disorders,&#xD;
             calcium homeostasis disorders and metabolic bone disease, pituitary gland disorder,&#xD;
             sex hormone disorders), cancer, serious mental disorder, or comorbid medical&#xD;
             conditions affecting either a) nutritional function: i.e., malabsorption problems due&#xD;
             to previous surgery in the gastrointestinal tract, inflammatory bowel disease, coeliac&#xD;
             disease, eating disorders, chronic pancreatitis, liver or kidney disease (those that&#xD;
             cannot convert vitamin D to its active form in the body), other conditions affecting&#xD;
             vitamin D or calcium absorption; b) musculoskeletal system: i.e., congenital systemic&#xD;
             skeletal dysplasia affecting bone density, inflammatory arthritis conditions (such as&#xD;
             rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and lupus), ongoing&#xD;
             tendinitis or muscle injuries not compatible with the exercise intervention; c)&#xD;
             cardiovascular system: i.e. congenital heart failure, congenital connective tissue&#xD;
             disorders affecting the aorta and/or arteries, other cardiovascular conditions not&#xD;
             compatible with the exercise intervention&#xD;
&#xD;
          -  the use of certain medications: bisphosphonates, PTH (teriparatide), Denosumab,&#xD;
             Raloksiphen, Prednisolone/steroids/androgenic steroids, high dose oestrogen (including&#xD;
             medroxyprogesterone acetate contraceptives) immunosuppressive medications/&#xD;
             chemotherapies, vitamin K, anti-epileptic medication (Lamotrigine, Phenytoin,&#xD;
             Phenobarbital, Carbamazepine, Primidone), proton pump inhibitors (PPIs), selective&#xD;
             serotonin receptor inhibitors (SSRIs), thiazolidinediones (TZDs), anticonvulsants,&#xD;
             hormone deprivation therapy, calcineurin inhibitors, and isotretinoin&#xD;
&#xD;
          -  other therapies that aim to increase bone mineral density, e.g., vibration therapy,&#xD;
             functional electrical stimulation (FES)&#xD;
&#xD;
          -  alternative medicine that interfere with vitamin D or calcium metabolism or affect&#xD;
             bone mineral density&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Norwegian School of Sport Sciences</name>
      <address>
        <city>Oslo</city>
        <zip>0863</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristin L Jonvik, PhD</last_name>
      <phone>+4794137624</phone>
      <email>kristinlj@nih.no</email>
    </contact>
    <contact_backup>
      <last_name>Linn C Risvang, MSc</last_name>
      <phone>+4790689951</phone>
      <email>linncr@nih.no</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>November 7, 2022</study_first_submitted>
  <study_first_submitted_qc>November 7, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2022</study_first_posted>
  <last_update_submitted>March 22, 2023</last_update_submitted>
  <last_update_submitted_qc>March 22, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Norwegian School of Sport Sciences</investigator_affiliation>
    <investigator_full_name>Kristin L. Jonvik</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Cerebral Palsy</mesh_term>
    <mesh_term>Spinal Dysraphism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

